Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Events: A Meta-Analysis of Randomized Clinical Trials

Objective. Data from randomized clinical trials with metabolic outcomes can be used to address concerns about potential issues of cardiovascular safety for newer drugs for type 2 diabetes. This meta-analysis was designed to assess cardiovascular safety of GLP-1 receptor agonists. Design and Methods....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Monami, Matteo, Cremasco, Francesco, Lamanna, Caterina, Colombi, Claudia, Desideri, Carla Maria, Iacomelli, Iacopo, Marchionni, Niccolò, Mannucci, Edoardo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi Publishing Corporation 2011
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3092497/
https://ncbi.nlm.nih.gov/pubmed/21584276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/215764
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak